South San Francisco-based Circle Pharma Inc, a macrocycle drug discovery and development company focused on intractable cancer targets, has raised $45 million in Series B financing. The Column Group led the round.
Source: Press Release
Circle Pharma grabs $45m Series B
South San Francisco-based Circle Pharma Inc, a macrocycle drug discovery and development company focused on intractable cancer targets, has raised $45 million in Series B financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: